Free Trial

Brainsway (BWAY) Stock Price, News & Analysis

Brainsway logo
$12.31 -0.33 (-2.61%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$12.30 -0.01 (-0.04%)
As of 07/11/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Brainsway Stock (NASDAQ:BWAY)

Key Stats

Today's Range
$12.11
$12.49
50-Day Range
$8.61
$13.37
52-Week Range
$5.98
$13.66
Volume
71,977 shs
Average Volume
68,233 shs
Market Capitalization
$232.66 million
P/E Ratio
61.55
Dividend Yield
N/A
Price Target
$14.25
Consensus Rating
Buy

Company Overview

Brainsway Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
54th Percentile Overall Score

BWAY MarketRank™: 

Brainsway scored higher than 54% of companies evaluated by MarketBeat, and ranked 698th out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Brainsway has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Brainsway has only been the subject of 1 research reports in the past 90 days.

  • Read more about Brainsway's stock forecast and price target.
  • Earnings Growth

    Earnings for Brainsway are expected to grow by 100.00% in the coming year, from $0.08 to $0.16 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Brainsway is 61.55, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.84.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Brainsway is 61.55, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.18.

  • Price to Book Value per Share Ratio

    Brainsway has a P/B Ratio of 3.72. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Brainsway's valuation and earnings.
  • Percentage of Shares Shorted

    0.81% of the float of Brainsway has been sold short.
  • Short Interest Ratio / Days to Cover

    Brainsway has a short interest ratio ("days to cover") of 3.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Brainsway has recently decreased by 0.56%, indicating that investor sentiment is improving.
  • Dividend Yield

    Brainsway does not currently pay a dividend.

  • Dividend Growth

    Brainsway does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.81% of the float of Brainsway has been sold short.
  • Short Interest Ratio / Days to Cover

    Brainsway has a short interest ratio ("days to cover") of 3.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Brainsway has recently decreased by 0.56%, indicating that investor sentiment is improving.
  • News Sentiment

    Brainsway has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.99 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Brainsway this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Brainsway insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    19.00% of the stock of Brainsway is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 30.11% of the stock of Brainsway is held by institutions.

  • Read more about Brainsway's insider trading history.
Receive BWAY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Brainsway and its competitors with MarketBeat's FREE daily newsletter.

BWAY Stock News Headlines

The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Brainsway Ltd. ADR
See More Headlines

BWAY Stock Analysis - Frequently Asked Questions

Brainsway's stock was trading at $9.43 on January 1st, 2025. Since then, BWAY shares have increased by 30.5% and is now trading at $12.31.

Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) released its earnings results on Tuesday, May, 13th. The company reported $0.04 EPS for the quarter, topping analysts' consensus estimates of $0.02 by $0.02. The firm had revenue of $11.54 million for the quarter, compared to analysts' expectations of $11.45 million. Brainsway had a trailing twelve-month return on equity of 7.35% and a net margin of 9.01%.
Read the conference call transcript
.

Brainsway (BWAY) raised $30 million in an IPO on Wednesday, April 17th 2019. The company issued 2,500,000 shares at $11.94 per share. Cantor served as the underwriter for the IPO.

Shares of BWAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Brainsway investors own include NVIDIA (NVDA), Broadcom (AVGO), Arista Networks (ANET), Jabil (JBL), e.l.f. Beauty (ELF), Novo Nordisk A/S (NVO) and AppLovin (APP).

Company Calendar

Last Earnings
5/13/2025
Today
7/12/2025
Next Earnings (Estimated)
8/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:BWAY
CIK
1505065
Fax
N/A
Employees
120
Year Founded
N/A

Price Target and Rating

High Price Target
$16.00
Low Price Target
$12.50
Potential Upside/Downside
+15.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.20
Trailing P/E Ratio
61.55
Forward P/E Ratio
153.88
P/E Growth
N/A
Net Income
$2.92 million
Net Margins
9.01%
Pretax Margin
10.22%
Return on Equity
7.35%
Return on Assets
4.72%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
5.03
Quick Ratio
4.75

Sales & Book Value

Annual Sales
$41.02 million
Price / Sales
5.67
Cash Flow
$0.25 per share
Price / Cash Flow
49.37
Book Value
$3.31 per share
Price / Book
3.72

Miscellaneous

Outstanding Shares
18,900,000
Free Float
15,305,000
Market Cap
$232.66 million
Optionable
Not Optionable
Beta
1.40
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:BWAY) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners